Browse > Article
http://dx.doi.org/10.3746/jkfn.2016.45.8.1208

Chlorogenic Acid Isomers from Sorbus commixta of Ulleung Island Origin and Their Inhibitory Effects against Advanced Glycation End Product (AGE) Formation and Radical Scavenging Activity  

Kim, Tae Hoon (Department of Food Science and Biotechnology, Daegu University)
Publication Information
Journal of the Korean Society of Food Science and Nutrition / v.45, no.8, 2016 , pp. 1208-1213 More about this Journal
Abstract
Advanced glycation end product (AGE) formation and reactive oxygen species are potential therapeutic targets for the prevention of diabetic nephropathy and other pathogenic complications. Activity-guided isolation of an ethylacetate-soluble portion of 80% methanolic extract from fruits of Sorbus commixta of the Ulleung Island origin using AGE formation inhibition assay led to the isolation and identification of three caffeoylquinic acid derivatives of a previously known structure, 3-O-caffeoylquinic acid (neochlorogenic acid; 1), 4-O-caffeoylquinic acid (cryptochlorogenic acid; 2), and 5-O-caffeoylquinic acid (chlorogenic acid; 3). The structures of these compounds were confirmed by interpretation of nuclear magnetic resonance and mass spectrometry data. Among the isolates, the major metabolite, neochlorogenic acid (1) showed the most potent inhibitory effect against AGE formation with an $IC_{50}$ value of $167.5{\pm}3.5{\mu}M$. Furthermore, all isolated chlorogenic acid isomers were evaluated for their radical scavenging activity against peroxynitrite, and structurally related isomers 1, 2, and 3 exhibited potent inhibitory effects in this radical scavenging assay. This result suggests that the monocaffeoyl quinic acid derivatives isolated from S. commixta might be beneficial for the regulation of diabetic complications and related diseases.
Keywords
Sorbus commixta; diabetic complications; chlorogenic acid isomers; advanced glycation end products (AGEs); peroxynitrite ($ONOO^-$);
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Doggrell SA. 2001. ALT-711 decreases cardiovascular stiffness and has potential in diabetes, hypertension and heart failure. Expert Opin Investig Drugs 10: 981-983.   DOI
2 Rahbar S, Figarola JL. 2003. Novel inhibitors of advanced glycation endproducts. Arch Biochem Biophys 419: 63-79.   DOI
3 Yokozawa T, Nakagawa T, Terasawa K. 2001. Effects of oriental medicines on the production of advanced glycation endproducts. J Tradit Med 18: 107-112.
4 Jang DS, Lee GY, Lee YM, Kim YS, Sun H, Kim DH, Kim JS. 2009. Flavan-3-ols having a $\gamma$-lactam from the roots of Actinidia arguta inhibit the formation of advanced glycation end products in vitro. Chem Pharm Bull 57: 397-400.   DOI
5 Ito H, Li P, Koreishi M, Nagatomo A, Nishida N, Yoshida T. 2014. Ellagitannin oligomers and a neolignan from pomegranate arils and their inhibitory effects on the formation of advanced glycation end products. Food Chem 152: 323-330.   DOI
6 Islam MN, Ishita IJ, Jung HA, Choi JS. 2014. Vicenin 2 isolated from Artemisia capillaris exhibited potent anti-glycation properties. Food Chem Toxicol 69: 55-62.   DOI
7 Bae K. 2000. The medicinal plants of Korea. Kyo-Hak Publishing Co., Seoul, Korea. p 236.
8 Bhatt LR, Bae MS, Kim BM, Oh GS, Cha KY. 2009. A chalcone glycoside from the fruits of Sorbus commixta Hedl. Molecules 14: 5323-5327.   DOI
9 Na MK, An RB, Min BS, Lee SM, Kim YH, Bae KH. 2002. Chemical constituents from Sorbus commixta. Nat Prod Sci 8: 62-65.
10 Na MK, An RB, Lee SM, Min BS, Kim YH, Bae KH, Kang SS. 2002. Antioxidant compounds from the stem bark of Sorbus commixta. Nat Prod Sci 8: 26-29.
11 Vinson JA, Howard III TB. 1996. Inhibition of protein glycation and advanced glycation end products by ascorbic acid and other vitamins and nutrients. J Nutr Biochem 7: 659-663.   DOI
12 Kooy NW, Royall JA, Ischiropoulos H, Beckman JS. 1994. Peroxynitrite-mediated oxidation of dihydrorhodamine 123. Free Radic Biol Med 16: 149-156.   DOI
13 Sato T, Iwaki M, Shimogaito N, Wu X, Yamagishi S, Takeuchi M. 2006. TAGE (toxic AGEs) theory in diabetic complications. Curr Mol Med 6: 351-358.   DOI
14 Nakatani N, Kayano S, Kikuzaki H, Sumino K, Katagiri K, Mitani T. 2000. Identification, quantitative determination, and antioxidative activities of chlorogenic acid isomers in prune (Prunus domestica L.). J Agric Food Chem 48: 5512-5516.   DOI
15 Merfort I. 1992. Caffeoylquinic acids from flowers of Arnica montana and Arnica chamissonis. Phytochemistry 31: 2111-2113.   DOI
16 Yamabe N, Kang KS, Park CH, Tanaka T, Yokozawa T. 2009. 7-O-Galloyl-D-sedoheptulose is a novel therapeutic agent against oxidative stress and advanced glycation endproducts in the diabetic kidney. Biol Pharm Bull 32: 657-664.   DOI
17 Lee YS, Kang YH, Jung JY, Lee S, Ohuchi K, Shin KH, Kang IJ, Park JHY, Shin HK, Lim SS. 2008. Protein glycation inhibitors from the fruiting body of Phellinus linteus. Biol Pharm Bull 31: 1968-1972.   DOI
18 Halliwell B. 1991. Drug antioxidant effects. A basis for drug selection?. Drugs 42: 569-605.   DOI
19 Thuraisingham RC, Nott CA, Dodd SM, Yaqoob MM. 2000. Increased nitrotyrosine staining in kidneys from patients with diabetic nephropathy. Kidney Int 57: 1968-1972.   DOI
20 Rice-Evans CA, Miller NJ, Paganga G. 1996. Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radic Biol Med 20: 933-956.   DOI
21 Choi HR, Choi JS, Han YN, Bae SJ, Chung HY. 2002. Peroxynitrite scavenging activity of herb extracts. Phytother Res 16: 364-367.   DOI
22 Vlassara H. 1996. Advanced glycation endproducts and atherosclerosis. Annal Med 28: 419-426.   DOI
23 Brownlee M. 2005. The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54: 1615-1625.   DOI
24 Ahmed N. 2005. Advanced glycation endproducts-role in pathology of diabetic complications. Diabetes Res Clin Pract 67: 3-21.   DOI
25 Huebschmann AG, Regensteiner JG, Vlassara H, Reusch JEB. 2006. Diabetes and advanced glycoxidation end products. Diabetes Care 29: 1420-1432.   DOI
26 Matsuda H, Wang T, Managi H, Yoshikawa M. 2003. Structural requirements of flavonoids for inhibition of protein glycation and radical scavenging activities. Bioorg Med Chem 11: 5317-5323.   DOI
27 Edelstein D, Brownlee M. 1992. Mechanistic studies of advanced glycosylation end product inhibition by aminoguanidine. Diabetes 41: 26-29.
28 Ceriello A. 2003. New insights on oxidative stress and diabetic complications may lead to a “casual” antioxidant therapy. Diabetes Care 26: 1589-1596.   DOI
29 Stitt A, Gardiner TA, Alderson NL, Canning P, Frizzell N, Duffy N, Boyle C, Januszewski AS, Chachich M, Baynes JW, Thorpe SR. 2002. The AGE inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetes. Diabetes 51: 2826-2832.   DOI